Johnson & Johnson is once again strengthened in court after a jury verdict in Los Angeles ruled in favor of the company in a lawsuit filed by the families of three women who alleged they developed ovarian cancer after prolonged use of the brand's cosmetic talc.
The court determined that the company did not act negligently in the marketing of its products, thus dismissing the claims of the plaintiffs, who maintained that the talc would have been related to the development of the disease.
A litigation that continues to mark the industry
The case is part of a wave of litigation that has affected Johnson & Johnson for years, with tens of thousands of lawsuits in the United States questioning the safety of talc in products for body use, especially in the genital area.
Although the company has achieved relevant victories in some recent trials, the legal landscape remains complex, with mixed verdicts and new lawsuits continuing to reach the courts. In parallel, other resolutions have imposed millionaire indemnities in similar cases, which keeps the debate open around scientific evidence and corporate responsibility.
Between science, perception and reputation
The use of talc in cosmetics has been subject to scrutiny over the last decade, especially for its possible relationship with ovarian cancer when used in intimate areas, a hypothesis that has driven both the withdrawal of some products from the market and the reformulation of others.
Johnson & Johnson, for its part, has repeatedly defended the safety of its products, assuring that scientific studies do not support a direct causal relationship between the use of talc and the development of cancer.